ESGO 2022: Sentinel node biopsy diminishes de use of adjuvant therapy in women with early cervical cancer in the SUCCOR cohort
Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 1 (2019)
JCM | Free Full-Text | Impact of Adjuvant Radiotherapy on Survival Outcomes in Intermediate-Risk, Early-Stage Cervical Cancer: Analyses Regarding Surgical Approach of Radical Hysterectomy
Frontiers | Prognostic Assessment of Cervical Cancer Patients by Clinical Staging and Surgical-Pathological Factor: A Support Vector Machine-Based Approach
Development of a management guide wheel for cervical cancer
Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteria - Gynecologic Oncology
Cervical Cancer Key points. - Cardiologia Siglo XXI | Facebook
Table 1 from Cervical cancer treated with reduced-volume intensity-modulated radiation therapy base on Sedlis criteria (NCCN VS RTOG). | Semantic Scholar
Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis - Gynecologic Oncology
Cervix Cancer Early Stage
Adjuvant treatment after radical surgery for cervical cancer with intermediate risk factors: is it time for an update? | International Journal of Gynecologic Cancer
Frontiers | Preoperative Prediction of Lymphovascular Space Invasion in Cervical Cancer With Radiomics –Based Nomogram
Management of Cervical Cancer
Retrospective analysis of prognosis using the Gynecology Oncology Group score of stage IB‑IIA node negative uterine cervical cancer after radical hysterectomy and trachelectomy
Summary of clinicopathological features of patients and tumours | Download Table
Long-term treatment outcomes/toxicities of definite chemoradiotherapy (intensity-modulated radiation therapy) for early-stage “bulky” cervical cancer and survival impact of histological subtype - ScienceDirect
Risk Stratification of <fc>Earlyâ•'Stage</fc> Cervical Cancer with <fc>Intermediateâ•'Risk</fc>
PDF) Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer
Stream episode Sedlis Criteria: A reanalysis of risk assessment with David Viveros-Carreño and Rene Pareja by BMJ talk medicine podcast | Listen online for free on SoundCloud
Current Oncology | Free Full-Text | Evaluation of Surgical Approaches and Use of Adjuvant Radiotherapy with Respect to Oncologic Outcomes in the Management of Clinically Early-Stage Cervical Carcinoma
Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study | British Journal of Cancer
Table 1 from Cervical biopsy and excision procedure specimens lack sufficient predictive value for lymph-vascular space invasion seen at hysterectomy for cervical cancer. | Semantic Scholar
Retrospective analysis of prognosis using the Gynecology Oncology Group score of stage IB‑IIA node negative uterine cervical cancer after radical hysterectomy and trachelectomy
มะเร็งปากมดลูก (Cervical cancer) - Department of Obstetrics and Gynecology Faculty of Medicine Chiang Mai University
